Business Standard

Jubilant Pharmova Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Board Meeting Intimation for Intimation Of Board Meeting And Recommendation Of Final Dividend If Any. Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors...Read More22/05/2024
Announcement - Appointment Of Mr. Harsher Singh As CEO Of Radiopharma Business Announcement - Appointment of Mr. Harsher Singh as CEO of Radiopharma Business02/05/2024
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure R...Read More30/04/2024
Closure Of Manufacturing Operations Of Solid Dosage Formulation Facility Of Jubilant Cadista Pharmaceuticals Inc. USA (Jubilant Cadista) A Subsidiary Located At Salisbury Maryland USA. Further Following The Status Change Of Jubilant Generics LimitedS (JGL Closure of manufacturing operations of Solid dosage formulation facility of Jubi...Read More18/04/2024
USFDA Communication USFDA Communication - Roorkee Facility17/04/2024
Compliance Certificate Under Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Compliance Certificate under Regulation 40(10) of the SEBI (Listing Obligations ...Read More10/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Intimation under Reg. 74(5) of the SEBI (DP) Regulations 201810/04/2024
Compliance Certificate For The Financial Year Ended March 31 2024. Intimation for compliance under Regulation 7(3)05/04/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) - Issuance of Letter of Confirmation04/04/2024
Intimation Under Regulation 30 Intimation under Regulation 3001/04/2024
Announcement under Regulation 30 (LODR)-Updates on Acquisition Update on acquisition of stake in O2 Renewable Energy XVI Private Limited29/03/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of loss of share certificate29/03/2024
Board Meeting Outcome for Change In Independent Directors Of The Company Change in Independent Directors of the Company26/03/2024
Announcement under Regulation 30 (LODR)-Change in Management Change in Independent Directors of the Company.26/03/2024
Announcement under Regulation 30 (LODR)-Change in Directorate Change in Independent Directors of the Company26/03/2024
Closure of Trading Window Intimation for Closure of Trading Window22/03/2024
Announcement under Regulation 30 (LODR)-Credit Rating Intimation for Credit Rating22/03/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of Loss of Share Certificate13/03/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of Loss of Share Certificate.13/03/2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Institutional investors meet scheduled to be held on March 12 2024.11/03/2024

Load more